Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol augmentation of exposure therapy for phobic anxiety disorders
NL-OMON28305Recruiting
- Sponsor
- Utrecht University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Agoraphobia with panic disorder (PD/A) and Social Anxiety Disorder (SAD) comparing Cannabidiol + exposure therapy with Placebo + exposure therapy (2 arms). Primary endpoint: Fear Questionnaire. Started Jun 2015; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
Agoraphobia with panic disorder (PD/A)Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NL-OMON28305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28305.